These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 351788

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Secondary parkinsonian syndromes].
    Fénelon G.
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S39-49. PubMed ID: 12773887
    [Abstract] [Full Text] [Related]

  • 23. Parkinson's disease: progression and mortality in the L-DOPA era.
    Di Rocco A, Molinari SP, Kollmeier B, Yahr MD.
    Adv Neurol; 1996 May; 69():3-11. PubMed ID: 8615142
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Introduction to the problems of dementia.
    Gooddy W.
    Proc Aust Assoc Neurol; 1969 May; 6():9-11. PubMed ID: 5349194
    [No Abstract] [Full Text] [Related]

  • 26. Parkinson's disease.
    Lieberman AN.
    Compr Ther; 1986 Mar; 12(3):25-9. PubMed ID: 3486090
    [No Abstract] [Full Text] [Related]

  • 27. [Therapy of parkinsonian syndromes with L-dopa. Results and prospects].
    Fazio C.
    Sist Nerv; 1970 Mar; 22(2):61-6. PubMed ID: 5504558
    [No Abstract] [Full Text] [Related]

  • 28. The Parkinson's complex: parkinsonism is just the tip of the iceberg.
    Langston JW.
    Ann Neurol; 2006 Apr; 59(4):591-6. PubMed ID: 16566021
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Neurochemical pathology and pharmacology of brain dopamine and acetylcholine: rational basis for the current drug treatment of Parkinsonism.
    Hornykiewicz O.
    Contemp Neurol Ser; 1971 Apr; 8():33-65. PubMed ID: 5162181
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Parkinson's disease in the aged].
    Kuzuhara S.
    Nihon Ronen Igakkai Zasshi; 1986 Jan; 23(1):17-22. PubMed ID: 3712819
    [No Abstract] [Full Text] [Related]

  • 34. The pathology of Parkinsonism. II. An interpretation with special reference to other changes in the aging brain.
    Alvord EC.
    Contemp Neurol Ser; 1971 Jan; 8():131-61. PubMed ID: 5162178
    [No Abstract] [Full Text] [Related]

  • 35. Parkinson's disease. A review.
    Voiculescu V.
    Rom J Neurol Psychiatry; 1991 Jan; 29(3-4):103-10. PubMed ID: 1820097
    [No Abstract] [Full Text] [Related]

  • 36. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB.
    Farmakol Toksikol; 1973 Jan; 26(4):481-9. PubMed ID: 4151298
    [No Abstract] [Full Text] [Related]

  • 37. Drug-induced extrapyramidal disorders.
    Chase TN.
    Res Publ Assoc Res Nerv Ment Dis; 1972 Jan; 50():448-71. PubMed ID: 4341954
    [No Abstract] [Full Text] [Related]

  • 38. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
    Haddenbrock S.
    Nervenarzt; 1966 May; 37(5):199-203. PubMed ID: 5298253
    [No Abstract] [Full Text] [Related]

  • 39. [Movement disorders of drug origin].
    Montastruc JL, Llau-Bousquet ME, Senard JM, Rascol O.
    Rev Prat; 1997 May 15; 47(10):1109-16. PubMed ID: 9208676
    [Abstract] [Full Text] [Related]

  • 40. [Pathophysiology and therapy of brain edema].
    Girke W, Lieske V.
    Med Klin; 1974 Jan 04; 69(1):1-11. PubMed ID: 4593990
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.